Stocks/DFTX

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

DFTX

↓ PDF (Pro)
Definium Therapeutics Inc. Common Shares
HealthcareBiotechnologyUnited StatesNASDAQ
$23.27
+3.88%today
MKT CAP
$2.5B
+5.1% · 1Y
Earnings History
+4.3%
-38.3%
-54.8%
-2.0%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$23.27
Low
$25.00
Analyst Mean
$39.53
High
$70.00
15 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-13.4x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership0.9%
Institutional Ownership66.6%
Short % of Float9.08%
Days to Cover5.7d
1 Week+5.2%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
SULLIVAN MARK ROfficerSale10,702$18.47$0.20M2026-03-25
BARROW ROBERT BChief Executive OfficerSale24,431$18.47$0.45M2026-03-25
KARLIN DANIEL ROLLINGSOfficerSale8,018$18.47$0.15M2026-03-25
SULLIVAN MARK ROfficerStock125,000$0.00$0.00M2026-02-03
ROBERTS BRANDI LChief Financial OfficerStock150,000$0.00$0.00M2026-02-03
Top Holders
HolderType% HeldValueΔ SharesAs of
Blackrock Inc.institution7.59%$0.19B+39.38%2025-12-31
Driehaus Capital Management, LLCinstitution5.99%$0.15B+110.21%2025-12-31
Avoro Capital Advisors LLCinstitution4.58%$0.11B+100.00%2025-12-31
Marshall Wace LLPinstitution2.73%$0.07B+24.93%2025-12-31
Vanguard Group Incinstitution2.38%$0.06B+28.77%2025-12-31
Trails Edge Capital Partners, LPinstitution2.35%$0.06B+100.00%2025-12-31
Janus Henderson Group PLCinstitution2.21%$0.05B+8513.20%2025-12-31
iShares Trust-iShares Russell 2000 ETFfund2.19%$0.05B+4.76%2026-03-31
State Street Corporationinstitution2.17%$0.05B+23.02%2025-12-31
Geode Capital Management, LLCinstitution2.14%$0.05B+27.85%2025-12-31
Octagon Capital Advisors LPinstitution2.04%$0.05B+4.69%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund0.98%$0.02B+26.56%2025-12-31
Fidelity Salem Street Trust-Fidelity Small Cap Index Fundfund0.84%$0.02B-1.42%2026-01-31
Fidelity Securities Fund-Fidelity Small Cap Growth Fundfund0.75%$0.02B+100.00%2026-01-31
iShares Trust-iShares Biotechnology ETFfund0.65%$0.02B-1.03%2026-03-31
iShares Trust-iShares Russell 2000 Value ETFfund0.53%$0.01B+3.63%2026-03-31
Fidelity Concord Street Trust-Fidelity Extended Market Index Fundfund0.51%$0.01B+8.21%2026-02-28
Vanguard Explorer Fundfund0.46%$0.01B-40.78%2026-01-31
SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETFfund0.44%$0.01B+5.98%2026-02-28
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fundfund0.43%$0.01B+26.18%2026-02-28
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total5
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for DFTX.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.